 NEW YORK, April 27, 2021 PRNewswire -- Q BioMed Inc. OTCQB: QBIO, a commercial stage biotech company, updates shareholders. In March 2021,it was announced that our technology partner, Mannin Research Inc. Mannin, is receiving up to CAD1.7 million in research and development funding from the National Research Council of Canada Industrial Research Assistance Program NRC IRAP to support the pre-clinical development of a therapeutic to treat Acute Respiratory Distress Syndrome in COVID-19. 